Exclusive: Cargill close to agreeing purchase of ADM cocoa unit - sources
Anonymousdarusuna.com
GAITHERSBURG, Md., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. ( NVAX ) today announced it will report its second quarter financial and operating results following the close of U.S. financial markets on Tuesday, August 8, 2017. Conference call details are as follows: Date: Tuesday, August 8, 2017 Time: 4:30 p.m. U.S. Eastern Time (ET) Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International) Passcode: 15614203 Webcast: www.novavax.com , Investors/ Events Conference call and webcast replay: Dates: Starts at 7:30 p.m. ET, August 8, 2017 until 7:30 pm ET, August 15, 2017 Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International) Passcode: 15614203 Webcast: www.novavax.com , Investors/ Events, until November 8, 2017 About Novavax Novavax, Inc. ( NVAX ) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Contact: Investor Relations Novavax, Inc. Andrea N. Flynn, Ph.D. Director, Investor Relations ir@novavax.com 240-268-2000 Westwicke Partners John Woolford john.woolford@westwicke.com 443-213-0506 Media Russo Partners, LLC David Schull Todd Davenport, Ph.D. david.schull@russopartnersllc.com 212-845-4271 This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Novavax, Inc. via GlobeNewswire HUG#2124891 View comments
Transform Your Health: 12 Essential Habits to Embrace Today
Discover 12 impactful habits to enhance your health and well-being, no matter your age. Start your journey today!